Results 31 to 40 of about 33,501 (182)

Novel scale for predicting thrombosis of the left atrium and its appendage before catheter ablation or cardioversion in patients with nonvalvular atrial fibrillation or atrial flutter

Кардиоваскулярная терапия и профилактика, 2023
Aim. To study the potential of predicting thrombosis of the left atrium (LA) and/or LA appendage (LAA) before catheter ablation (CA) or elective cardioversion in patients with nonvalvular atrial fibrillation (NAF) or atrial flutter (AFL) using indicators
I. A. Zaigraev, I. S. Yavelov, O. M. Drapkina, E. V. Bazaeva   +3 more
doaj   +1 more source

Usefulness of transesophageal echocardiography before cardioversion in atrial arrhythmias

Cardiology Journal, 2021
BACKGROUND: Although many thromboembolism risk factors are well defined, formation of thrombus or dense spontaneous contrast (sludge) in the left atrium remains enigmatic and confounding.
Katarzyna Kosmalska, Małgorzata Rzyman, Paweł Miękus, Natasza Gilis-Malinowska, Radosław Nowak, Marcin Fijałkowski   +5 more
doaj   +1 more source

Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department

Biomedicines
Background: Atrial fibrillation (AF) is a common arrhythmia in the emergency department (ED). We investigated the role of N-terminal pro b-type natriuretic peptide (NT-proBNP) in predicting both the outcome of AF cardioversion and the risk of AF ...
Antonios Diakantonis, Christos Verras, Sofia Bezati, Vasiliki Bistola, Ioannis Ventoulis, Maria Velliou, Antonios Boultadakis, Ignatios Ikonomidis, John T. Parissis, Effie Polyzogopoulou   +9 more
doaj   +1 more source

Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative?

Рациональная фармакотерапия в кардиологии, 2023
Aim. To compare different scores in assessment of risk of left atrial or its appendage thrombosis (LAAT) in patients with non-valvular atrial fibrillation (AF) or atrial flutter (AFL) undergoing transesophageal echocardiography before catheter ablation ...
I. A. Zaigraev, I. S. Yavelov, O. M. Drapkina, E. V. Bazaeva   +3 more
doaj   +1 more source

Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling [PDF]

, 2003
<b>Objective:</b> Chronic beta-adrenoceptor antagonist (β-blocker) treatment reduces the incidence of reversion to AF in patients, possibly via an adaptive myocardial response.
Kane, K.A., Norrie, J., Rankin, A.C., Russell, J.A., Workman, A.J.   +4 more
core   +1 more source

Safety evaluation of electrical cardioversion in the presence left ventricular thrombus

Journal of Stroke and Cerebrovascular Diseases
Background: Electrical cardioversion is an effective and safe procedure for most patients. While left atrial thrombus is an absolute contraindication for an elective cardioversion, there is limited data on cardioversion in patients with left ventricular ...
M Marwan Dabbagh, MD, Saqer Alkharabsheh, MD, Mohamed Khayata, MD, Patrick Collier, MD   +3 more
doaj   +1 more source

Rate-Control or Rhythm-Contol: Where do we stand? [PDF]

, 2005
Atrial fibrillation is the most common sustained rhythm disturbance and its prevalence is increasing worldwide due to the progressive aging of the population.
A, Dello Russo, F, Andreotti, F, Bellocci, G, Pelargonio, G, Trotta, L, Testa, M, Casella   +6 more
core   +1 more source

Pharmacological Therapy for Fibrillations

Journal of Arrhythmia, 2007
Human beings suffer from two different kinds of fibrillations: one is atrial fibrillation (AF) and the other is ventricular fibrillation (VF). AF is the most common sustained arrhythmia and VF is the most serious.
Akira Fujiki, MD
doaj   +1 more source

Frequency Analysis of Atrial Fibrillation From the Surface Electrocardiogram [PDF]

, 2004
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Neither the natural history of AF nor its response to therapy are sufficiently predictable by clinical and echocardiographic parameters.
Bollmann, Andreas, Husser, Daniela, Olsson, Bertil, Sornmo, Leif, Stridh, Martin   +4 more
core  

Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the Caerphilly Study [PDF]

, 2001
We have previously reported that plasma fibrin D-dimer (a marker of turnover of cross-linked Fibrin) showed a strong and independent association with incident ischaemic heart disease (IHD) in the Caerphilly Study cohort of 1,998 men a-ed 49-65.
Lowe, G.D.O., Rumley, A., Rumley, J., Sweetnam, P.M., Yarnell, J.W.G.   +4 more
core   +1 more source